Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells. | Elife | 2024 | 38738857 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 promotes esophageal cell carcinoma progression by enhancing EIF4A1 translation. | Cancer Cell Int | 2024 | 38724996 | PubTator, text mining | PubMed |
| The MYCN 5' UTR as a therapeutic target in neuroblastoma. | Cell Rep | 2024 | 38662542 | PubTator, text mining | PubMed |
| PDCD4 restricts PRRSV replication in an eIF4A-dependent manner and is antagonized by the viral nonstructural protein 9. | J Virol | 2024 | 38557170 | PubTator, text mining | PubMed |
| Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes. | Biomolecules | 2024 | 38540795 | PubTator, text mining | PubMed |
| dCas13-mediated translational repression for accurate gene silencing in mammalian cells. | Nat Commun | 2024 | 38467613 | PubTator, text mining | PubMed |
| Knockdown of EIF4G1 in NSCLC induces CXCL8 secretion. | Front Pharmacol | 2024 | 38405671 | PubTator, text mining | PubMed |
| The NP protein of Newcastle disease virus dictates its oncolytic activity by regulating viral mRNA translation efficiency. | PLoS Pathog | 2024 | 38377149 | PubTator, text mining | PubMed |
| Visualization of translation reorganization upon persistent ribosome collision stress in mammalian cells. | Mol Cell | 2024 | 38340715 | PubTator, text mining | PubMed |
| Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging. | Heliyon | 2024 | 38304805 | PubTator, text mining | PubMed |
| Exploration and bioinformatic prediction for profile of mRNA bound to circular RNA BTBD7_hsa_circ_0000563 in coronary artery disease. | BMC Cardiovasc Disord | 2024 | 38267845 | PubTator, text mining | PubMed |
| Computational inference of eIF4F complex function and structure in human cancers. | Proc Natl Acad Sci U S A | 2024 | 38266053 | PubTator, text mining | PubMed |
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications. | Cell Death Dis | 2024 | 38238286 | PubTator, text mining | PubMed |
| Retracted: Platelet-Rich Plasma-Derived Exosomal USP15 Promotes Cutaneous Wound Healing via Deubiquitinating EIF4A1. | Oxid Med Cell Longev | 2024 | 38234562 | PubTator, text mining | PubMed |
| A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer. | Proc Natl Acad Sci U S A | 2024 | 38232291 | PubTator, text mining | PubMed |
| Identification and validation of molecular subtypes and prognostic signature for stage I and stage II gastric cancer based on neutrophil extracellular traps. | Open Med (Wars) | 2024 | 38221932 | PubTator, text mining | PubMed |
| Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor. | Life Sci Alliance | 2024 | 38129098 | PubTator, text mining | PubMed |
| Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses. | J Med Chem | 2024 | 38127656 | PubTator, text mining | PubMed |
| RNA helicase EIF4A1-mediated translation is essential for the GC response. | Life Sci Alliance | 2024 | 38011999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=5